Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies

Paul D. Jones, Nicola M. Wolf, Christophe Morisseau, Paul Whetstone, Bertold Hock, Bruce D. Hammock

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Inhibition of the mammalian soluble epoxide hydrolase (sEH) is a promising new therapy in the treatment of disorders resulting from hypertension and vascular inflammation. A spectrophotometric assay (4-nitrophenyl-trans-2,3- epoxy-3-phenylpropyl carbonate, NEPC) is currently used to screen libraries of chemicals; however this assay lacks the required sensitivity to differentiate the most potent inhibitors. A series of fluorescent α-cyanoester and α-cyanocarbonate epoxides that produce a strong fluorescent signal on epoxide hydrolysis by both human and murine sEH were designed as potential substrates for an in vitro inhibition assay. The murine enzyme showed a broad range of specificities, whereas the human enzyme showed the highest specificity for cyano(6-methoxy-naphthalen-2-yl)methyl trans-[(3-phenyloxiran-2-yl)methyl] carbonate. An in vitro inhibition assay was developed using this substrate and recombinant enzyme. The utility of the fluorescent assay was confirmed by determining the IC50 values for a series of known inhibitors. The new IC50 values were compared with those determined by spectrophotometric NEPC and radioactive tDPPO assays. The fluorescent assay ranked these inhibitors on the basis of IC50 values, whereas the NEPC assay did not. The ranking of inhibitor potency generally agreed with that determined using the tDPPO assay. These results show that the fluorescence-based assay is a valuable tool in the development of sEH inhibitors by revealing structure-activity relationships that previously were seen only by using the costly and labor-intensive radioactive tDPPO assay.

Original languageEnglish (US)
Pages (from-to)66-75
Number of pages10
JournalAnalytical Biochemistry
Volume343
Issue number1
DOIs
StatePublished - Aug 1 2005

Fingerprint

Epoxide Hydrolases
Carbonates
Inhibitory Concentration 50
Assays
Epoxy Compounds
Substrates
Enzymes
Small Molecule Libraries
Structure-Activity Relationship
Blood Vessels
Hydrolysis
Fluorescence
Hypertension
Inflammation
4-nitrophenyl
In Vitro Techniques
Therapeutics

Keywords

  • α-Cyanocarbonate
  • α-Cyanoester
  • Fluorescent substrate
  • Kinetic assay
  • Soluble epoxide hydrolase

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Jones, P. D., Wolf, N. M., Morisseau, C., Whetstone, P., Hock, B., & Hammock, B. D. (2005). Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies. Analytical Biochemistry, 343(1), 66-75. https://doi.org/10.1016/j.ab.2005.03.041

Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies. / Jones, Paul D.; Wolf, Nicola M.; Morisseau, Christophe; Whetstone, Paul; Hock, Bertold; Hammock, Bruce D.

In: Analytical Biochemistry, Vol. 343, No. 1, 01.08.2005, p. 66-75.

Research output: Contribution to journalArticle

Jones, PD, Wolf, NM, Morisseau, C, Whetstone, P, Hock, B & Hammock, BD 2005, 'Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies', Analytical Biochemistry, vol. 343, no. 1, pp. 66-75. https://doi.org/10.1016/j.ab.2005.03.041
Jones, Paul D. ; Wolf, Nicola M. ; Morisseau, Christophe ; Whetstone, Paul ; Hock, Bertold ; Hammock, Bruce D. / Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies. In: Analytical Biochemistry. 2005 ; Vol. 343, No. 1. pp. 66-75.
@article{277ea22fdc7c4fdd944b1fda17535564,
title = "Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies",
abstract = "Inhibition of the mammalian soluble epoxide hydrolase (sEH) is a promising new therapy in the treatment of disorders resulting from hypertension and vascular inflammation. A spectrophotometric assay (4-nitrophenyl-trans-2,3- epoxy-3-phenylpropyl carbonate, NEPC) is currently used to screen libraries of chemicals; however this assay lacks the required sensitivity to differentiate the most potent inhibitors. A series of fluorescent α-cyanoester and α-cyanocarbonate epoxides that produce a strong fluorescent signal on epoxide hydrolysis by both human and murine sEH were designed as potential substrates for an in vitro inhibition assay. The murine enzyme showed a broad range of specificities, whereas the human enzyme showed the highest specificity for cyano(6-methoxy-naphthalen-2-yl)methyl trans-[(3-phenyloxiran-2-yl)methyl] carbonate. An in vitro inhibition assay was developed using this substrate and recombinant enzyme. The utility of the fluorescent assay was confirmed by determining the IC50 values for a series of known inhibitors. The new IC50 values were compared with those determined by spectrophotometric NEPC and radioactive tDPPO assays. The fluorescent assay ranked these inhibitors on the basis of IC50 values, whereas the NEPC assay did not. The ranking of inhibitor potency generally agreed with that determined using the tDPPO assay. These results show that the fluorescence-based assay is a valuable tool in the development of sEH inhibitors by revealing structure-activity relationships that previously were seen only by using the costly and labor-intensive radioactive tDPPO assay.",
keywords = "α-Cyanocarbonate, α-Cyanoester, Fluorescent substrate, Kinetic assay, Soluble epoxide hydrolase",
author = "Jones, {Paul D.} and Wolf, {Nicola M.} and Christophe Morisseau and Paul Whetstone and Bertold Hock and Hammock, {Bruce D.}",
year = "2005",
month = "8",
day = "1",
doi = "10.1016/j.ab.2005.03.041",
language = "English (US)",
volume = "343",
pages = "66--75",
journal = "Analytical Biochemistry",
issn = "0003-2697",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies

AU - Jones, Paul D.

AU - Wolf, Nicola M.

AU - Morisseau, Christophe

AU - Whetstone, Paul

AU - Hock, Bertold

AU - Hammock, Bruce D.

PY - 2005/8/1

Y1 - 2005/8/1

N2 - Inhibition of the mammalian soluble epoxide hydrolase (sEH) is a promising new therapy in the treatment of disorders resulting from hypertension and vascular inflammation. A spectrophotometric assay (4-nitrophenyl-trans-2,3- epoxy-3-phenylpropyl carbonate, NEPC) is currently used to screen libraries of chemicals; however this assay lacks the required sensitivity to differentiate the most potent inhibitors. A series of fluorescent α-cyanoester and α-cyanocarbonate epoxides that produce a strong fluorescent signal on epoxide hydrolysis by both human and murine sEH were designed as potential substrates for an in vitro inhibition assay. The murine enzyme showed a broad range of specificities, whereas the human enzyme showed the highest specificity for cyano(6-methoxy-naphthalen-2-yl)methyl trans-[(3-phenyloxiran-2-yl)methyl] carbonate. An in vitro inhibition assay was developed using this substrate and recombinant enzyme. The utility of the fluorescent assay was confirmed by determining the IC50 values for a series of known inhibitors. The new IC50 values were compared with those determined by spectrophotometric NEPC and radioactive tDPPO assays. The fluorescent assay ranked these inhibitors on the basis of IC50 values, whereas the NEPC assay did not. The ranking of inhibitor potency generally agreed with that determined using the tDPPO assay. These results show that the fluorescence-based assay is a valuable tool in the development of sEH inhibitors by revealing structure-activity relationships that previously were seen only by using the costly and labor-intensive radioactive tDPPO assay.

AB - Inhibition of the mammalian soluble epoxide hydrolase (sEH) is a promising new therapy in the treatment of disorders resulting from hypertension and vascular inflammation. A spectrophotometric assay (4-nitrophenyl-trans-2,3- epoxy-3-phenylpropyl carbonate, NEPC) is currently used to screen libraries of chemicals; however this assay lacks the required sensitivity to differentiate the most potent inhibitors. A series of fluorescent α-cyanoester and α-cyanocarbonate epoxides that produce a strong fluorescent signal on epoxide hydrolysis by both human and murine sEH were designed as potential substrates for an in vitro inhibition assay. The murine enzyme showed a broad range of specificities, whereas the human enzyme showed the highest specificity for cyano(6-methoxy-naphthalen-2-yl)methyl trans-[(3-phenyloxiran-2-yl)methyl] carbonate. An in vitro inhibition assay was developed using this substrate and recombinant enzyme. The utility of the fluorescent assay was confirmed by determining the IC50 values for a series of known inhibitors. The new IC50 values were compared with those determined by spectrophotometric NEPC and radioactive tDPPO assays. The fluorescent assay ranked these inhibitors on the basis of IC50 values, whereas the NEPC assay did not. The ranking of inhibitor potency generally agreed with that determined using the tDPPO assay. These results show that the fluorescence-based assay is a valuable tool in the development of sEH inhibitors by revealing structure-activity relationships that previously were seen only by using the costly and labor-intensive radioactive tDPPO assay.

KW - α-Cyanocarbonate

KW - α-Cyanoester

KW - Fluorescent substrate

KW - Kinetic assay

KW - Soluble epoxide hydrolase

UR - http://www.scopus.com/inward/record.url?scp=22144444583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144444583&partnerID=8YFLogxK

U2 - 10.1016/j.ab.2005.03.041

DO - 10.1016/j.ab.2005.03.041

M3 - Article

C2 - 15963942

AN - SCOPUS:22144444583

VL - 343

SP - 66

EP - 75

JO - Analytical Biochemistry

JF - Analytical Biochemistry

SN - 0003-2697

IS - 1

ER -